Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2024

Sep 10, 2024

30786_dirs_2024-09-10_f52c22ee-7a6d-4026-91d3-5ea97747b298.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2024-09-06

Reporting Person: PEI MELINDA LITHERLAND (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-09-06 Restricted Stock Units $0 A 308 Acquired Bio-Rad A Common Stock (308) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F2: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.